IGF-1 LR3 Consent Template
$599
IGF-1 LR3 is an investigational synthetic peptide and a modified form of Insulin-like Growth Factor-1 (IGF-1), a naturally occurring hormone involved in cellular growth, muscle development, and metabolic regulation. It is being explored for its potential to support muscle recovery, lean body composition, and cellular repair.
Before beginning treatment, all patients complete an informed consent process covering how IGF-1 LR3 works, its experimental status, potential risks, and patient responsibilities. As IGF-1 LR3 is not FDA-approved and clinical evidence remains limited, all use is considered experimental and is conducted under qualified medical supervision.
